United States · Seed startup

Who invested in Verosint

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Cybersecurity

Funding summaryUpdated 26 Oct 2026

$4.0Mraised across 1 round since 2023, from 1 source

Latest round
Seed, $4.0MOct 2023
Investors
1
See who backed them

The rounds

  1. Oct 2023
    Seed$4.0M

    Source recorded

Founders and team

From Verosint's own website: 13 on the team.

  • Fran RoschChief Executive Officer
  • Fun FactsChief Executive Officer
  • Jeffrey KowalskiSenior Vice President, Legal
  • Claire ReillyChief Nursing Informatics Officer and VP Clinical Operations
  • Adrian GrbavacChief Customer Officer
  • Carl MurphyChief Revenue Officer
  • Chip HughesChief Product Officer
  • Cindy ZhouChief Marketing Officer
  • Dr. Sean KellyChief Medical and Growth Officer
  • Joel Burleson-DavisChief Technology and Security Officer
  • John FernandezChief Financial Officer
  • Kelliann McCabeChief People Officer
  • Tom TimperioChief Engineering Officer

Everyone who backed them

Silverton PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Verosint

Who invested in Verosint?

Verosint's investors include Silverton Partners.

How much has Verosint raised?

Verosint has raised $4.0M across 1 round since 2023.

When did Verosint last raise?

Verosint's most recent round was a Seed of $4.0M in Oct 2023.

What was Verosint's biggest round?

Its most recent round, $4.0M in Oct 2023, is also its largest on record.

Who backed Verosint first?

Verosint's first round on record, in Oct 2023, was backed by Silverton Partners.

What stage is Verosint at?

Verosint's latest named round is a Seed, in Oct 2023.

Where is Verosint based?

Verosint is based in the United States.

Companies like Verosint

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.